The conference focuses on oligometastatic disease, an important area of modern cancer medicine in which patients have a limited number of metastatic lesions. Advances in imaging, systemic therapies and metastasis-directed treatments are creating new possibilities for personalised cancer care and multidisciplinary treatment strategies.

The Oligometastatic Disease Conference in Zurich provides a platform for experts to share current scientific insights, discuss clinical approaches and explore emerging treatment concepts. Topics relevant to the field include metastasis-directed therapy, radiotherapy, surgery, systemic treatment, precision oncology, imaging and multidisciplinary cancer care.

With its interdisciplinary focus, the conference is particularly relevant for medical oncologists, radiation oncologists, surgeons, radiologists, researchers and other healthcare professionals involved in the management of metastatic cancer. The event offers an opportunity to exchange knowledge and explore innovative approaches to improving outcomes for patients with oligometastatic disease.